Insurtech Funding Drops 44.6% in Q3 2026
Insurtech investment experienced a significant contraction in the third quarter of 2026, with total funding dropping 44.6% to $1.36 billion compared to the previous quarter. According to data from Gallagher Re, this decline was primarily driven by a sharp reduction in large-scale transactions. Deals valued at $100 million or more fell to $660 million, down from $1.67 billion in the second quarter. Despite the decrease in total dollar volume, the overall number of deals remained relatively stable, decreasing slightly to 104 from 107.
The funding landscape remained heavily dominated by artificial intelligence, which accounted for $1.13 billion of the total, or 83.2% of all investment across 72 individual deals. While overall funding dipped, early-stage investment showed resilience, increasing by 20.1% to $317.29 million. The average size of these early-stage deals grew to $8.35 million, and the number of such transactions rose to 56. Seed and angel-stage startups secured 42.3% of all deals, marking the highest share for this category since the fourth quarter of 2022.
A notable shift occurred in sector focus, as life and health (L&H) insurtechs outperformed property and casualty (P&C) firms for only the third time since early 2020. L&H funding rose 23.1% quarter-over-quarter to $741.54 million, supported by four of the quarter's five mega-rounds. These included $200 million for Angle Health, $150 million for Forus, $108 million for Thatch, and $100 million for Penelope Health. Conversely, P&C funding fell 66.7% to $0.61 billion.
Geographically, U.S.-based insurtechs captured a record 64.4% of all deals, with 67 of the 104 total transactions going to companies in the United States. This trend was mirrored by investor concentration, as 75.9% of active investors in the third quarter were U.S.-based. Meanwhile, direct investment from insurance and reinsurance companies continued to pull back, with insurers backing 25 investments in the third quarter, a decrease from 51 in the same period of 2025.
For industry observers, the cooling of mega-round activity suggests a more cautious capital environment for mature startups, contrasting with the sustained interest in early-stage innovation and AI-driven solutions. The shift toward U.S.-centric investment and the waning presence of direct insurer-backed deals may signal a strategic pivot in how legacy carriers engage with the insurtech ecosystem, favoring partnerships over direct equity investment.
Why it matters
The decline in mega-round funding and insurer-backed deals suggests a shift toward more cautious, early-stage investment strategies within the insurtech sector.
FAQ
How did Q3 2026 insurtech funding compare to the quarterly average?
The $1.36 billion raised in the third quarter was approximately 5% higher than the quarterly average of $1.28 billion recorded since 2023.
Which sector received more funding in the third quarter: Life & Health or Property & Casualty?
Life and health-focused insurtechs outraised property and casualty-focused insurtechs, with L&H funding reaching $741.54 million compared to $0.61 billion for P&C.
What percentage of insurtech funding was captured by AI-focused companies?
AI-focused companies captured 83.2% of all third-quarter insurtech funding, totaling $1.13 billion.
Source: Risk & Insurance. See the original source for full details.
Scan with your phone
Scan with your phone